We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
You can change your cookie settings at any time.
10 June 1921 to 9 April 2021
The first annual report from the UK Recovery Champion outlines the work he has undertaken since his appointment and sets out his future work programme.
A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice.
This report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the impact on drug treatment.
A review of the evidence on the 2016 drug strategy by the Advisory Council on the Misuse of Drugs (ACMD).
An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD).
A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD).
Minutes of the Advisory Council on the Misuse of Drugs.
Figures on methylphenidate base and methylphenidate hydrochloride importation between 2010 and 2012 were requested.
Information regarding various aspects of the FRANK drugs advisory service.
This publication scheme is in accordance with the ACMD policy on openness and transparency detailed in the ACMD’s Code of Practice.
Agenda details for ACMD meeting on 29 march 2010
Request for details of the background that led to David Blunkett's decision to downgrade cannabis from a class B drug to a class C drug.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.